METTL14 facilitated the proliferation of MDS cells by promoting the m6A modification of SETBP1 mRNA through the formation of the METTL3-METTL14 complex, leading to enhanced stability of SETBP1 mRNA and subsequent activation of the PI3K-AKT signaling pathway. Here, METTL3 is linked to myelodysplastic syndrome.